Axim Biotechnologies Inc (ID) (AXIM)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form DEF 14C - Other definitive information statements

Form PRE 14C - Other preliminary information statements

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:June 09, 2023...

Current Report Filing (8-k)

0001514946 false 0001514946 2023-05-23 2023-05-23 SECURITIES AND EXCHANGE COMMISSION Washington, D.C...